Histogen

$1.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 5:55 PM UTC today

Why Robinhood?

You can buy or sell Histogen and other stocks, options, and ETFs commission-free!

About HSTO

Histogen Inc. Common Stock, also called Histogen, is a clinical-stage therapeutics company, which focuses on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Its reproducible manufacturing process yields multiple biologic products from a single bioreactor, including cell conditioned medium, human extracellular matrix and hair stimulating complex, creating a spectrum of products for a variety of markets from one core technology. The company was founded by Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. The listed name for HSTO is Histogen Inc. Common Stock.

CEO
Richard W. Pascoe
Employees
6
Headquarters
San Diego, California
Founded
2005
Market Cap
36.15M
Price-Earnings Ratio
Dividend Yield
Average Volume
8.30M
High Today
$1.21
Low Today
$1.15
Open Price
$1.21
Volume
799.88K
52 Week High
$7.50
52 Week Low
$0.749

HSTO Earnings

-$1.52
-$1.01
-$0.51
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like

BCEI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure